Loading...
Please wait, while we are loading the content...
Similar Documents
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis
| Content Provider | Scilit |
|---|---|
| Author | Ryan, Gerard Jahnke, Nikki Remmington, Tracey |
| Copyright Year | 2012 |
| Description | Journal: Cochrane Database of Systematic Reviews Cystic fibrosis is a genetic disorder in which abnormal mucus in the lungs is associated with susceptibility to persistent infection. Pulmonary exacerbations are when symptoms of infection become more severe. Antibiotics are an essential part of treatment for exacerbations and inhaled antibiotics may be used alone or in conjunction with oral antibiotics for milder exacerbations or with intravenous antibiotics for more severe infections. Inhaled antibiotics do not cause the same adverse effects as intravenous antibiotics and may prove an alternative in people with poor access to their veins. |
| ISSN | 2573508X |
| e-ISSN | 14651858 |
| DOI | 10.1002/14651858.cd008319.pub2 |
| Journal | Cochrane Database of Systematic Reviews |
| Volume Number | 12 |
| Language | English |
| Publisher | Wiley-Blackwell |
| Publisher Date | 2012-12-12 |
| Access Restriction | Open |
| Subject Keyword | Journal: Cochrane Database of Systematic Reviews Respiratory System Pulmonary Exacerbations Inhaled Antibiotics Fibrosis Cystic |
| Content Type | Text |
| Resource Type | Article |